Sociable Pharma Blog
Highlights from ERS 2011 - Day 2
posted by Pengfei Lu in
Tuesday, September 27, 2011
The oral sessions of the European Respiratory Society (ERS) 2011 Annual Congress kicked off on Sunday with large amounts of new data presented on asthma and COPD, together with a number of interesting symposia, hosted by some of the world’s leading experts in respiratory disease, in which the most important treatment challenges and latest developments were discussed.
Another front in the IBD biologics battle opens up
posted by Nick Bennett in
Monday, September 26, 2011
The next phase in the battle between anti-TNF therapies in inflammatory bowel disease began on Friday when the US FDA approved infliximab (Janssen Biotech’s Remicade) to treat moderate to severe ulcerative colitis in children 6 years and older who have failed conventional therapy.
Approval had been long expected and was based on safety and efficacy data from a multicenter, randomized, open-label study in 60 children aged between 6 - 17 years with active disease who did not respond to treatment with corticosteroids or immunomodulators.
Review of BSPAR annual meeting day 1
posted by Maria Pawlowska in
Friday, September 23, 2011
Today was the first day of the British Society for Paediatric & Adolescent Rheumatology (BSPAR) annual meeting and the organizers had done a fantastic job of filling the schedule with very interesting (and entertaining!) presentations. Important issues such as patient sexual health, uveitis and the usefulness of ultrasound for paediatric rheumatologists were covered.
However, the key theme that seemed to run throughout the day was the issue of transitioning patients to adult care and maintaining continuity of care.
Tackling the big challenges in asthma and COPD - Part 2
posted by Pengfei Lu in
Thursday, September 22, 2011
Welcome to Part 2 of Sociable Pharma’s preview of the upcoming European Respiratory Society (ERS) 2011 Annual Congress, a meeting that will address the important challenges facing doctors in the treatment of asthma and COPD.
Tackling the big challenges in asthma and COPD - Part 1
posted by Pengfei Lu in
Wednesday, September 21, 2011
Welcome to Part 1 of Sociable Pharma’s preview of the upcoming European Respiratory Society (ERS) 2011 Annual Congress, a meeting that will address the important challenges facing doctors in the treatment of asthma and COPD.